Pfizer Dodges Suit Over Retirement Fund Stock Plummet

Law360, New York (April 1, 2013, 6:54 PM EDT) -- Pfizer Inc. does not owe damages to employees whose company-managed retirement funds lost value when news emerged of possible dangerous side effects in drugs Bextra and Celebrex, a federal judge ruled Friday, dismissing a putative class action against the pharmaceutical giant.

Case law provides a broad protection to companies that buy their own stock with retirement fund money, U.S. District Judge Laura Taylor Swain said in a written opinion, dismissing a case brought by workers who participated in Pfizer retirement funds after their shares plummeted in...
To view the full article, register now.




Case Information

Case Title

In re Pfizer ERISA Litigation

Case Number



New York Southern

Nature of Suit

Labor: E.R.I.S.A.


Laura Taylor Swain

Date Filed

December 20, 2004

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.